Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
0°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Avinger, Inc. - Common Stock
(NQ:
AVGR
)
0.4740
-0.1240 (-20.74%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Avinger, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Avinger to Present at LD Micro Investor Conference
October 19, 2022
Via
ACCESSWIRE
Avinger's Return On Capital Employed Insights
September 07, 2022
According to data from Benzinga Pro, during Q2, Avinger's (NASDAQ:AVGR) reported sales totaled $2.13 million. Despite a 18.02% increase in earnings, the company posted a loss of $4.21 million.
Via
Benzinga
Interim Data from IMAGE-BTK Clinical Trial Presented at AMP 2022
September 01, 2022
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 19, 2022
Via
Benzinga
Avinger: Q2 Earnings Insights
August 11, 2022
Avinger (NASDAQ:AVGR) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:01 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Avinger Reports Second Quarter 2022 Results
August 11, 2022
Via
ACCESSWIRE
Avinger, Inc. Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-the-Market Under Nasdaq Rules
August 08, 2022
Via
ACCESSWIRE
Avinger to Announce Second Quarter 2022 Results on August 11
August 05, 2022
Via
ACCESSWIRE
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
August 04, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 04, 2022
Via
Benzinga
Avinger Announces $5 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules
August 04, 2022
Via
ACCESSWIRE
Avinger Announces Filing of 510(k) Submission for Tigereye ST Image-Guided CTO Crossing System
July 06, 2022
REDWOOD CITY, CA / ACCESSWIRE / July 6, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Exposures
Product Safety
Avinger Expands International Presence with First Commercial Shipment to Chile
June 21, 2022
REDWOOD CITY, CA / ACCESSWIRE / June 21, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
July 21, 2022
Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
Via
Benzinga
Avinger Announces Presentations by Key Opinion Leaders and Live Case Transmission at LINC 2022
June 15, 2022
REDWOOD CITY, CA / ACCESSWIRE / June 15, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference
June 06, 2022
REDWOOD CITY, CA / ACCESSWIRE / June 6, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 27, 2022
Via
Benzinga
Avinger Announces Key Opinion Leader Presentation and Live Case at Vascular Conferences in Germany
May 16, 2022
REDWOOD CITY, CA / ACCESSWIRE / May 16, 2022 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Recap: Avinger Q1 Earnings
May 10, 2022
Avinger (NASDAQ:AVGR) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Avinger missed estimated earnings by...
Via
Benzinga
99 Biggest Movers From Yesterday
May 12, 2022
Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company.
Via
Benzinga
52 Stocks Moving In Wednesday's Mid-Day Session
May 11, 2022
Gainers Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247...
Via
Benzinga
Avinger Reports First Quarter 2022 Results
May 10, 2022
REDWOOD CITY, CA / ACCESSWIRE / May 10, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided,...
From
Avinger, Inc.
Via
AccessWire
Exposures
COVID-19
Product Safety
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
May 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 04, 2022
Gainers 1Life Healthcare (NASDAQ:ONEM) shares moved upwards by 22.4% to $9.58 during Wednesday's after-market session. The market value of their outstanding shares is at $1.8 billion. The company's, Q1...
Via
Benzinga
Avinger to Announce First Quarter 2022 Results on May 10
April 29, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Avinger, Inc.
Via
AccessWire
12 Health Care Stocks Moving In Monday's After-Market Session
April 25, 2022
Gainers
Via
Benzinga
Avinger Announces Full Commercial Launch of Lightbox 3
April 19, 2022
REDWOOD CITY, CA / ACCESSWIRE / April 19, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided,...
From
Avinger, Inc.
Via
AccessWire
Avinger Announces Issuance of Three New U.S. Patents in March 2022
March 30, 2022
16 New U.S. and International Patents Issued over Past Year REDWOOD CITY, CA / ACCESSWIRE / March 30, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and...
From
Avinger, Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Avinger Regains Compliance with Nasdaq Listing Requirements
March 29, 2022
REDWOOD CITY, CA / ACCESSWIRE / March 29, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system...
From
Avinger, Inc.
Via
AccessWire
Avinger's Return On Capital Employed Overview
March 23, 2022
Benzinga Pro data, Avinger (NASDAQ:AVGR) reported Q4 sales of $2.40 million. Earnings fell to a loss of $5.00 million, resulting in a 1.71% decrease from last quarter. In Q3,...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.